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Summary
Streptococcus pneumoniae (pneumococcus) is the
most common cause of community-acquired pneumo-
nia, with high morbidity and mortality worldwide [1]. A
major feature of pneumococcal pneumonia is an abun-
dant neutrophil infiltration [2]. It was recently shown
that activated neutrophils release neutrophil extracel-
lular traps (NETs), which contain antimicrobial pro-
teins bound to a DNA scaffold. NETs provide a high lo-
cal concentration of antimicrobial components [3] and
bind, disarm, and kill microbes extracellularly [4].
Here, we show that pneumococci are trapped but, un-
like many other pathogens, not killed by NETs. NET
trapping in the lungs, however, may allow the host to
confine the infection, reducing the likelihood for the
pathogen to spread into the bloodstream. DNases
are expressed by many Gram-positive bacterial patho-
gens [5, 6], but their role in virulence is not clear.
Expression of a surface endonuclease encoded by
endA [7] is a common feature of many pneumococcal
strains. We show that EndA allows pneumococci to
degrade the DNA scaffold of NETs and escape. Fur-
thermore, we demonstrate that escaping NETs pro-
motes spreading of pneumococci from the upper
airways to the lungs and from the lungs into the blood-
stream during pneumonia.
Results
Pneumococci Are Captured but Not Killed
by NETs In Vitro
The pneumococcal strain TIGR4 (serotype 4) belongs to
a clonal type with high capacity to cause invasive dis-
ease in humans [8]. TIGR4 pneumococci interact with
neutrophil extracellular traps (NETs). Figures 1A–1B
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4 These authors contributed equally to this work.show the filamentous NET structures stained for DNA
(blue) and the granular enzyme neutrophil elastase
(NE) (red). Pneumococci (green) are captured by NETs
(arrows) in a dose-dependant fashion (Figures 1A–1B).
We tested whether NETs kill pneumococci (Figure 1C).
To distinguish between phagocytic and NET microbici-
dal activity, we blocked phagocytosis with the actin-
polymerization inhibitor Cytochalasin D before infecting
neutrophils [4, 9, 10] (see Figure S1 in the Supplemental
Data available online). TIGR4 pneumococci were com-
pletely resistant to NET killing. The Gram-negative bac-
teria Shigella flexneri served as a positive control and
were efficiently killed by NETs (Figure 1C).
Pneumococcal Endonuclease EndA Degrades
Extracellular DNA
We demonstrated that TIGR4 pneumococci degrade
extracellular DNA by incubating bacteria with salmon
sperm DNA (Figure 2A). The DNase activity was almost
exclusively associated with the bacteria, and only mar-
ginal activity could be detected in the culture superna-
tant (Figure S2). We identified the pneumococcal gene
endA in the TIGR4 genome as a likely homolog of the
Streptococcus pyogenes DNase genes spd and sda
[5]. endA is known to encode a membrane bound nucle-
ase (TIGR4 SP1964) important for DNA uptake [7, 11, 12].
We made the TIGR4 isogenic knockout, TIGR4D(endA),
and showed that it failed to degrade extracellular DNA
(Figure 2A), although the mutant grew as efficiently as
wild-type TIGR4 in vitro (Figure S3). Reintroducing endA
into TIGR4D(endA) generated TIGR4D(endA)V(endA) and
restored the DNase activity (Figure 2A). TIGR4D(endA),
like the wild-type, was not killed by the antimicrobial
activity of NETs (Figure 1C). Our data show that EndA
represents a major nuclease that allows TIGR4 pneumo-
cocci to degrade extracellular DNA efficiently.
Pneumococci Destroy NETs
Because the scaffold of NETs is DNA [4], we tested
whether pneumococcal EndA affects NET integrity. Acti-
vated neutrophils were incubated with either culture
medium RPMI (Figure 2B), bovine pancreatic DNase
(Figure 2C), TIGR4D(endA) (Figure 2D), or TIGR4
(Figure 2E). After 30 min incubation, the samples were
fixed and stained for DNA (blue) and NE (red). NETs
were intact in cells incubated with medium but disinte-
grated after incubation with DNase or TIGR4. In contrast,
infection with TIGR4D(endA) did not affect the NET
integrity.
We also examined the disintegration of NETs by EndA
with a functional assay using S. flexneri as a sensitive re-
porter for the antimicrobial activity of NETs (Figure 2F).
We first exposed NETs to culture medium, bovine pan-
creatic DNase, TIGR4, or TIGR4D(endA) and then in-
fected them with S. flexneri, which, unlike pneumococci,
are sensitive to NET killing (Figure 1C). Figure 2F shows
that NETs exposed to culture medium (control) killed
around 50% of the S. flexneri inoculum. Bacterial killing
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402Figure 1. S. pneumoniae Is Trapped but Not Killed by NETs In Vitro
(A and B) Neutrophils were stimulated with PMA and infected with FITC-labeled TIGR4 pneumococci (green) at a multiplicity of infection (MOI) of
1 (A) or 100 (B). Five minutes postinfection, the samples were fixed and stained for DNA (blue) and neutrophil elastase (NE, red). Scale bars
represent 20 mm. NETs are identified as filamentous structures. The dose-dependent trapping of pneumococci (arrows) in NET structures
(MOI 1 versus MOI 100) can be observed.
(C) The percentage of bacterial killing by NETs (gray) and by phagocytosis (black), which together make up total killing, is shown for Shigella
flexneri (pos. control) and pneumococci [TIGR4, TIGR4D(endA)]. Mean and standard error of the mean (SEM) are shown both for total and for
phagocytosis killing. Assays were performed at least three independent times for each strain. Pneumococci were killed neither by NETs nor
by phagocytosis.was reduced to around 30% after treatment with bovine
DNase. NETs exposed to TIGR4 also only killed around
30% ofS. flexneri inoculum. Significantly, NETs exposed
to TIGR4D(endA) killed as efficiently as the control.
In a further demonstration that EndA degrades NETs,
the release of NE was used as an indicator. This enzyme
is normally bound to NETs and found at very low concen-
trations in culture supernatants. Indeed, a very low NE
level was detected in the supernatant of NETs incubated
with culture medium (Figure 2G, control). The concentra-
tion of NE increased in the supernatant when NETs were
incubated with DNase or TIGR4. Significantly, very low
NE concentrations were found in the supernatant of
NETs incubated with TIGR4D(endA). The released NE
came exclusively from NETs and not from intact neutro-
phils because DNase treatment did not increase NE in
the supernatant of unstimulated neutrophils (Figure S4).
Also, in the absence of DNase, stimulated neutrophilsshowed low NE levels in the supernatant. Taken to-
gether, these three approaches demonstrate that EndA
degrades the DNA scaffold of NETs and thereby de-
stroys their functional integrity.
EndA Allows Pneumococcal Escape from NETs
To analyze the effect of DNase activity on pneumococcal
trapping, we infected activated neutrophils with TIGR4,
TIGR4D(endA), and TIGR4D(endA)V(endA). Five (Fig-
ures 3A–3C) and thirty (Figures 3D–3F) minutes after in-
fection, samples were fixed and stained for pneumo-
cocci (green), DNA (blue), and NE (red). Five minutes
postinfection (p.i.), similar numbers of bacteria of all
three strains were associated with NETs (arrows). Thirty
minutes p.i., however, there were very few NETs in cul-
tures infected with TIGR4 or TIGR4D(endA)V(endA),
and the bacteria were lost in the wash. In contrast,
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(A) Salmon sperm DNA was incubated with TIGR4, TIGR4D(endA), and TIGR4D(endA)V(endA) and resolved on an agarose gel. A sample without
pneumococci was used as negative control. DNA incubated with TIGR4 or TIGR4D(endA)V(endA) was degraded. No degradation was observed
when DNA was incubated with TIGR4D(endA), which lacks the DNase gene.
(B–E) Neutrophils were activated to make NETs and treated with medium (control) (B), bovine pancreatic DNase (C), TIGR4D(endA) pneumococci
(D), or TIGR4 pneumococci (E). The samples were stained for DNA (blue) and NE (red). Scale bars represent 20 mm. NETs are degraded in samples
treated with bovine DNase or TIGR4 pneumococci.
(F) NET-mediated killing of the reporter strain of S. flexneri. The NETs were exposed to RPMI medium (control), bovine pancreatic DNase, TIGR4,
or TIGR4D(endA) pneumococci. We measured killing of S. flexneri as a reporter of NET antimicrobial activity. Mean and SEM are shown. The
assay was performed three times and analyzed with the nonparametric Mann-Whitney test. A p value < 0.05 was considered significant. Shigella
flexneri were killed less efficiently after NETs were treated with DNase or DNase-producing pneumococci.
(G) NETs were treated with RPMI medium (control), bovine pancreatic DNase, TIGR4, or TIGR4D(endA) pneumococci. We measured the NE con-
centration in the supernatant as a reporter of NET degradation. Mean and SEM are shown. The assay was performed three times and analyzed
with the nonparametric Mann-Whitney test. A p value < 0.05 was considered significant. Higher concentrations of NE could be measured in the
supernatant of neutrophils cultures after exposure to TIGR4 compared to TIGR4D(endA), indicating that the TIGR4-encoded DNase EndA de-
graded NETs, thereby releasing NE.abundant TIGR4D(endA) bacteria remained associated
with intact NETs (Figure 3E).
NETs Are Made in Pneumococcal Pneumonia
To study NET formation in vivo, we infected C57BL/6
mice intranasally with the TIGR4 strain to induce pneu-
monia. The animals were sacrificed 48 hr p.i., and lungs
were stained for the NET markers DNA (blue), histone H1
(green), and a 40 kDa neutrophil-specific surface marker
(red). In mock-infected mice (Figures 4A and 4C), DNA
and histone H1 both were restricted to nuclei. In contrast,
in TIGR4-infected lungs, an influx of activated neutro-
phils, accompanied by extracellular DNA and histone
H1, was observed (Figures 4B and 4D). The NETs local-
ized to alveoli, as shown in the merged image. Similar re-
sults were obtained after infection with TIGR4D(endA)
(data not shown). A mean of 48% (6 18% standard devi-
ation [SD]) of the inspected lung fields contained NETs
after infection with TIGR4 as quantified by analyzing
a total of 364 fields (403 objective) in the lungs of ten dif-
ferent mice. No NETs were observed in mock-infected
animals.NET Destruction Affects S. pneumoniae Virulence
The role of EndA in vivo was tested by comparing infec-
tions with TIGR4, TIGR4D(endA), and TIGR4D(endA)V
(endA) after intranasal inoculation (Figure 4E). The endA
mutant exhibited a delayed onset of severe disease, and
at 65 hr postinfection, mice infected with the endA mu-
tant had around 60% survival whereas animals infected
with either TIGR4 or its isogenic revertant TIGR4D
(endA)V(endA) had around 40% survival. These differ-
ences had a p value lower than 0.05 by a Kaplan-
Meier-analysis log-rank test.
We also investigated the role of endA in virulence by
infecting mice with two strains simultaneously and de-
termining the competitive index (CI). The CI is the ratio
of the number of bacteria recovered from each strain in
the same organ (e.g., lungs) and determines the relative
fitness of an individual strain to survive in that organ [13].
A CI of 1 is obtained when both strains are recovered in
equal numbers from a specific organ and indicates that
both strains are equally fit. A CI of 0.1 is obtained when
10-fold less bacteria are recovered from one strain
than from the other, and it indicates that the strain is
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Neutrophils were activated to make NETs and infected at a MOI of 100 with TIGR4, TIGR4D(endA), or TIGR4D(endA)V(endA). Samples were fixed
5 (top panels) or 30 min (bottom panels) after infection and stained for DNA (blue) and NE (red). Pneumococci were labeled with FITC (green)
before infection. Scale bars represent 20 mm. Five minutes p.i., NET formation was observed in all samples (A–C), and similar numbers of
TIGR4 (A), TIGR4D(endA) (B), and TIGRD(endA)V(endA) (C) were initially associated with NETs (arrows). Thirty minutes after infection, only
TIGR4D(endA) pneumococci were still bound to NETs (E), whereas the EndA-expressing TIGR4 (D) and TIGR4D(endA)V(endA) (F) detached
from the strongly degraded NETs and were washed away. Thus, endA-encoded DNase activity liberates bacteria from NETs.severely attenuated. Furthermore, by comparing the CI
from different organs, it is possible to analyze how suc-
cessfully a strain spreads within the host. This approach
is possible because EndA is not secreted by pneumo-
cocci and therefore cannot rescue the endA mutant
[7, 12] (Figure S2).
Mice were infected intranasally with TIGR4 and
TIGR4D(endA) in a 1:1 ratio, and the bacterial load was
determined in the upper respiratory tract (URT), the
lungs, and the bloodstream. Figure 4F shows that at
a terminal stage of pneumonia, similar numbers of
TIGR4 and TIGR4D(endA) were recovered from the
URT (CI w1), indicating that both strains are equally
competent in colonizing the upper airways. In contrast,
9–12 times more TIGR4 than TIGR4D(endA) bacteria
were recovered from the lungs and from the blood-
stream (CI = 0.11 and 0.08, respectively). Already 24 hr
after infection, there were four times more TIGR4 than
mutant bacteria in the bloodstream (CI = 0.23, Figure 4G).
This difference was even more pronounced at 48 hr p.i.,
with 12.5 times as many TIGR4 (CI = 0.08, Figure 4G).
A competition experiment between TIGR4D(endA) and
TIGR4D(endA)V(endA) yielded similar results (Figures
4H–4I), demonstrating that the phenotype of TIGR4D
(endA) is specific for the endA mutation. These data
strongly suggest that although TIGR4D(endA) is stillable to colonize the upper airways to the same extent
as TIGR4, it is less efficient in reaching and propagating
in the lungs and in the bloodstream.
Many Different S. pneumoniae Strains Degrade NETs
S. pneumoniae comprises many different serotypes and
clonal types. To determine whether degradation of
NETs is a common virulence attribute, we tested pneu-
mococcal strains of seven different capsular types (se-
rotypes 1, 2, 4, 7F, 9V, 14, and 19F). This collection rep-
resents strains belonging to clonal types with different
capacity to cause invasive disease in humans [8, 14].
All the strains tested, except one belonging to a clone
of serotype 1, showed strong EndA activity as tested
on salmon sperm DNA (Figure 5A). Analogously, all
strains with EndA activity degraded NETs, as measured
by the release of NE (Figure 5B). This shows that
NET degradation is a common feature of pathogenic
pneumococci.
Discussion
Streptococcus pneumoniae is the main cause of com-
munity-acquired pneumonia, and in 20%–30% of these
cases, bacteria spread to the bloodstream [15]. The
main clinical characteristic of pneumococcal pneumonia
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(A–D) C57BL/6 mice were infected intranasally with either bacterial growth medium (A and C) or TIGR4 pneumococci (B and D). Forty-eight hours
postinfection, the lungs were removed and stained for DNA (blue), histone H1 (green), and a neutrophil-specific surface marker (red). Scale bars
represent 20 mm ([C] and [D] represent close-ups). Whereas in mock-infected controls (A and C), DNA and histone both are restricted to nuclei, in
infected samples (B and D), extracellular DNA and histone can be observed, lining the alveoli. This shows that NETs are formed in murine pneu-
mococcal pneumonia.
(E) C57BL/6 mice were infected intranasally with TIGR4, TIGR4D(endA), or TIGR4D(endA)V(endA) pneumococci (n = 66). Two independent ob-
servers assessed the health status to assign pathology scores as described previously [8]. Mice infected with TIGR4D(endA) had a delayed onset
of severe disease and a significantly higher survival rate than both TIGR4 and TIGR4D(endA)V(endA) as determined by the Kaplan-Meier-analysis
log-rank test (A p value < 0.05 was considered significant).
(F–I) C57BL/6 mice were infected intranasally with a 1:1 mix of TIGR4 and TIGR4D(endA) (F-G) or a 1:1 mix of TIGR4D(endA)V(endA) and TIGR4D
(endA) (H–I). Bacterial counts in the upper respiratory tract (URT), lungs, and bloodstream were determined when mice were sacrificed (F and H).
Bacterial counts per ml blood were determined 24 hr and 48 hr postinfection (G and I). The competitive index shown is based on the ratio of num-
ber of bacteria recovered from the two strains. A competitive index of 1 indicates equal numbers of wild-type and mutant bacteria. Values lower
than 1 indicate that the mutant is outcompeted. Each dot represents one mouse. Median values are indicated by horizontal bars. All strains are
able to colonize the URT of mice to the same extent. However, TIGR4D(endA) is outcompeted by both TIGR4 (F–G) and TIGR4D(endA)V(endA)
(H–I) in the lungs and in the bloodstream. This shows that TIGR4D(endA) is defective in its invasion ability.is inflammation with an abundant recruitment of neutro-
phils [2]. Pneumococci are typically expressing an anti-
phagocytic capsule, suggesting that phagocytosis early
during infection might provide little protection to the
host. Also, because the vast majority of pneumococcal
infections result in nasopharyngeal colonization without
further spread, there must be mechanisms operating in
the host that confine the organism to its local site of in-
fection. We therefore hypothesized that extracellular
capture of pneumococci in NETs represents one such
mechanism.
Here, we show that NETs trap pneumococci (Figure 1).
This is in agreement with previous studies showing thatNETs trap other microbes such as Salmonella enterica
serovar Typhimurium, Shigella flexneri, Staphylococcus
aureus [4], and Candida albicans [16]. In contrast to
other microbes, pneumococci are not killed by NETs
(Figure 1C). Yet, NET trapping of pneumococci could
be important in restricting the dissemination of the bac-
teria. In pneumococcal infections, NETs might initially
capture the bacteria, thus reducing their spread by con-
fining bacteria to specific areas.
An efficient means to evade NETs would be to disinte-
grate the DNA backbone. EndA is a bacterial cell-associ-
ated endonuclease [7, 12] that allows pneumococci to
efficiently degrade extracellular DNA and to escape
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Show DNase Activity and Degrade NETs
(A) Salmon sperm DNA was incubated with
pneumococcal strains of the indicated sero-
types and separated on an agarose gel. A
sample without pneumococci was used as
negative control. Differences in DNase activ-
ity of the tested strains can be observed,
with especially low DNase activity for the
serotype 1 strain.
(B) NETs were treated with RPMI medium
(control), pneumococcal strains of different
serotypes, or bovine pancreatic DNase. The
concentration of NE in the supernatant was
measured as a reporter of NET degradation.
Mean and SEM are shown. The assay was
performed three times and analyzed with
the nonparametric Mann-Whitney test. A p
value < 0.05 was considered significant.
Compared to TIGR4 (serotype 4), a signifi-
cantly lower concentration of NE could be
measured in neutrophils exposed to pneu-
mococci of type 1. This is reflecting the type
1’s low DNase activity and capability to de-
grade NETs.from NETs by degrading their DNA backbone (Figures 2
and 3). Pneumococci lacking endA are not able to free
themselves from NETs (Figure 3) and are also less viru-
lent after intranasal challenge in mice (Figure 4). endA
knockouts were outcompeted by the wild-type strain in
the lungs and in the bloodstream but not in the upper re-
spiratory tract, where initial colonization occurs (Fig-
ure 4). Because EndA is cell bound [7, 12], it is unable
to rescue endA mutant bacteria from NETs in mixed in-
fections. The cell association of EndA implies that it
can only degrade NETs locally in the vicinity of trapped
bacteria. This probably explains why NETs remain pres-
ent in the lungs after infections with pneumococci
expressing EndA.
Our data suggest a pivotal role for EndA in facilitating
progression from localized pneumococcal infections in
the upper airways into an invasive disease. Hence, our
findings explain why endA was identified as a virulence
gene by signature-tagged mutagenesis [17].
Pneumococcal strains that express EndA at high
levels are likely to be able to escape NETs, making
them more prone to cause an invasive disease. Even
though most pneumococcal strains tested, all capable
of causing invasive disease in humans, express EndA
and destroy NETs, the enzyme levels produced might
differ. In this study, a strain of type 1 (PJ1354), exhibited
a significantly lower DNase activity compared to the
other strains tested (Figure 5). It has recently been
shown that serotype 1 isolates of this clonal type cause
less severe invasive infections, compared to most other
pneumococcal types, with a high proportion of pneumo-
nia in humans [14]. Hence, differences in DNase activity
might endow individual strains of this highly variablespecies with different risks of causing severe invasive
disease in man.
Conclusions
This study presents a novel role for neutrophils in innate
immune responses to bacterial infections. We show the
presence of neutrophil extracellular traps (NETs) in
pneumococcal pneumonia and that NETs are able to
trap, but not kill, pneumococci. We further find that
EndA, a pneumococcal nuclease, is able to degrade
NETs. Our findings suggest that EndA acts as a virulence
determinant counteracting host-mediated trapping by
NETs, thereby promoting bacterial spread from local
sites to the lungs and from the lungs to the bloodstream.
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